Get started
Author

Fumi Nakamura

Observed names: F. Nakamura, Nakamura, Fumi
ORCID: 0009-0008-8554-1864
Observed ORCID: 0009-0008-8554-1864
OpenAlex ID: A5044169149
Incidence of acquired pure red cell aplasia: a nationwide epidemiologic analysis with 2 registry databases in Japan
2022 · Hideyuki Nakazawa, Kaoko Sakai, et al. · Blood Advances · 29
PDF
Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia
2023 · Yuta Kaito, Emi Sugimoto, et al. · Haematologica · 24
PDF
Efficient production of human neutrophils from iPSCs that prevent murine lethal infection with immune cell recruitment
2021 · Masashi Miyauchi, Yusuke Ito, et al. · Blood · 24
Extraosseous plasmacytoma in the nasal cavity after rituximab therapy against pulmonary MALT lymphoma
2016 · Fumi Nakamura, Fumihiko Nakamura, et al. · Annals of Hematology · 5
HDAC inhibitors repress Tek and Angpt1 expression and proliferation in RUNX1-MECOM-type leukemia cells
2025 · Fumi Nakamura, Yuka Nakamura, et al. · Leukemia Research · 4
Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12)
2023 · Fumi Nakamura, Sachiko Seo, et al. · International Journal of Hematology · 2
PDF
DNAM-1/Tigit/CD155/CD112 Axis Is a Novel Target of NK-Cell Therapy in Acute Myeloid Leukemia
2022 · Yuta Kaito, Emi Sugimoto, et al. · Blood · 2
Emergence of t(3;21)(q26.2;q22) during eltrombopag treatment in a patient with relapsed aplastic anemia who received chemotherapy for angioimmunoblastic T-cell lymphoma
2022 · Fumi Nakamura, Yuka Nakamura, et al. · Leukemia Research Reports · 2
PDF
Development of Philadelphia chromosome-negative acute myeloid leukemia with IDH2 and NPM1 mutations in a patient with chronic myeloid leukemia who showed a major molecular response to tyrosine kinase inhibitor therapy
2021 · Fumi Nakamura, Honoka Arai, et al. · International Journal of Hematology · 2
[Effective treatment of POEMS syndrome accompanied by plasmacytoma with lenalidomide, dexamethasone, and local irradiation].
2020 · Wataru Takahashi, Motoshi Ichikawa, et al. · PubMed · 2
Outcomes and Prognostic Scoring System for Elderly Patients with Acute Myeloid Leukemia
2020 · Fumi Nakamura, Sachiko Seo, et al. · Blood · 1
PECAM is an effective and safe anthracycline-containing third-line regimen for patients with relapsed or refractory non-Hodgkin lymphoma
2020 · Fumi Nakamura, Honoka Arai, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1
Phase II study of the triple combination of rabbit ATG , ciclosporin and eltrombopag in patients with transfusion‐dependent aplastic anaemia: West Japan Hematology Study Group (W‐ JHS ) AA02 trial
2026 · Fumi Nakamura, Ken Ishiyama, et al. · British Journal of Haematology
PDF
DNAM-1/TIGIT/CD155/ CD112 Axis Is a Novel Target of Natural Killer Cell Therapy in Acute Myeloid Leukemia
2022 · Kaito, Yuta, Sugimoto, Emi, et al. · Institutional Repositories DataBase (IRDB)
PDF
Genetically Engineered Hematopoietic Progenitors Derived from Human Induced Pluripotent Stem Cells Achieve the Feeder-Free and Robust Production of Neutrophils with the Functional Capacity In Vivo
2019 · Masashi Miyauchi, Yusuke ITO, et al. · Blood
Investigation of an effective method for the production of iPSC-derived neutrophil
2018 · Fumi Nakamura · The Japanese Society of Hematology
UP-1.197: Evaluation of Therapeutic Effect of Solifenacin in Patients with Overactive Bladder Using OABSS, Bladder Diary and KHQ in Comparison with Propiverine
2009 · T. Yamanishi, T. Mizuno, et al. · Urology
Works count: 17
Citation count: 97
H-index: 4
I10-index: 3
Year
Topic
Type